Cargando…
Developing Clinically Relevant Dissolution Specifications for Oral Drug Products—Industrial and Regulatory Perspectives
A meeting that was organized by the Academy of Pharmaceutical Sciences Biopharmaceutics and Regulatory Sciences focus groups focused on the challenges of Developing Clinically Relevant Dissolution Specifications (CRDS) for Oral Drug Products. Industrial Scientists that were involved in product devel...
Autores principales: | McAllister, Mark, Flanagan, Talia, Boon, Karin, Pepin, Xavier, Tistaert, Christophe, Jamei, Masoud, Abend, Andreas, Kotzagiorgis, Evangelos, Mackie, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022466/ https://www.ncbi.nlm.nih.gov/pubmed/31878006 http://dx.doi.org/10.3390/pharmaceutics12010019 |
Ejemplares similares
-
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series
por: McAllister, Mark, et al.
Publicado: (2022) -
Recent Advances in Development and Application of Physiologically-Based Pharmacokinetic (PBPK) Models: a Transition from Academic Curiosity to Regulatory Acceptance
por: Jamei, Masoud
Publicado: (2016) -
FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms
por: Brown, Cynthia K., et al.
Publicado: (2011) -
Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective
por: Riedmaier, Arian Emami, et al.
Publicado: (2020) -
A Method to Assess the Relevance of Nanomaterial Dissolution during Reactivity Testing
por: Peijnenburg, Willie J. G. M., et al.
Publicado: (2020)